MHH Researchers scrutinize EC Regulation
500.000 Euros of funding for an assessment of regulatory impact on Advanced Therapies
01-Dec-2010 -
A team of researchers from the United Kingdom, Sweden, Austria and Germany, with Professor Dr Martin Hildebrandt, Integrated Research and Treatment Center Transplantation (IFB-Tx), Hannover Medical School MHH) as coordinator, are setting up a platform for Academic GMP Institutions. GMP - Good ...
clinical trials
concrete
diseases
+5